0001209191-20-049966.txt : 20200910
0001209191-20-049966.hdr.sgml : 20200910
20200910162807
ACCESSION NUMBER: 0001209191-20-049966
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200908
FILED AS OF DATE: 20200910
DATE AS OF CHANGE: 20200910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Babler Martin
CENTRAL INDEX KEY: 0001435618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 201168937
MAIL ADDRESS:
STREET 1: C/O INFINITY PHARMACEUTICALS, INC.
STREET 2: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neoleukin Therapeutics, Inc.
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-732-2133
MAIL ADDRESS:
STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
DATE OF NAME CHANGE: 20140128
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-08
0
0001404644
Neoleukin Therapeutics, Inc.
NLTX
0001435618
Babler Martin
C/O NEOLEUKIN THERAPEUTICS, INC.
360-1616 EASTLAKE AVENUE EAST
SEATTLE
WA
98102
1
0
0
0
Stock Option (Right to Buy)
12.25
2020-09-08
4
A
0
50000
0.00
A
2030-09-08
Common Stock
50000
50000
D
The option vests as to 1/3 of the total shares on each of September 8, 2021, September 8, 2022 and September 8, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Kris McGrew, as Attorney-in-Fact for Martin Babler
2020-09-10